human embryonic kidney 293 hek293 cell lines  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human embryonic kidney 293 hek293 cell lines
    ( A ) <t>HEK293</t> cells were treated with 0.5 µM doxorubicin (DOX) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( B ) HEK293 cells were treated with 10 mM hydroxyurea (HU) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( C ) HEK293 cells were treated with 10 nM camptothecin (CPT) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( D ) HeLa cells were treated with 10 mM HU, and incubated as indicated. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, RPA32, phospho-ATM/ATR substrates, and α-tubulin. ( E ) HeLa cells were treated with or without 0.5 µM DOX, 10 nM CPT, 10 mM HU, and 20 Gy ionizing radiation (IR) for 4 hr. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, phospho-ATM/ATR substrates, and α-tubulin. ( F ) HeLa cells were treated with 0.5 μM DOX, and analyzed by immunoblotting for MASTL, α-tubulin, Aurora A, Aurora B, CDK1, cyclin B1, and phospho-ATM/ATR substrates. ( G ) SCC38 cells were incubated with or without HU and caffeine, as indicated, and analyzed by immunoblotting for MASTL and β-actin.
    Human Embryonic Kidney 293 Hek293 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney 293 hek293 cell lines/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney 293 hek293 cell lines - by Bioz Stars, 2023-10
    86/100 stars

    Images

    1) Product Images from "The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery"

    Article Title: The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery

    Journal: eLife

    doi: 10.7554/eLife.86976

    ( A ) HEK293 cells were treated with 0.5 µM doxorubicin (DOX) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( B ) HEK293 cells were treated with 10 mM hydroxyurea (HU) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( C ) HEK293 cells were treated with 10 nM camptothecin (CPT) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( D ) HeLa cells were treated with 10 mM HU, and incubated as indicated. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, RPA32, phospho-ATM/ATR substrates, and α-tubulin. ( E ) HeLa cells were treated with or without 0.5 µM DOX, 10 nM CPT, 10 mM HU, and 20 Gy ionizing radiation (IR) for 4 hr. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, phospho-ATM/ATR substrates, and α-tubulin. ( F ) HeLa cells were treated with 0.5 μM DOX, and analyzed by immunoblotting for MASTL, α-tubulin, Aurora A, Aurora B, CDK1, cyclin B1, and phospho-ATM/ATR substrates. ( G ) SCC38 cells were incubated with or without HU and caffeine, as indicated, and analyzed by immunoblotting for MASTL and β-actin.
    Figure Legend Snippet: ( A ) HEK293 cells were treated with 0.5 µM doxorubicin (DOX) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( B ) HEK293 cells were treated with 10 mM hydroxyurea (HU) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( C ) HEK293 cells were treated with 10 nM camptothecin (CPT) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( D ) HeLa cells were treated with 10 mM HU, and incubated as indicated. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, RPA32, phospho-ATM/ATR substrates, and α-tubulin. ( E ) HeLa cells were treated with or without 0.5 µM DOX, 10 nM CPT, 10 mM HU, and 20 Gy ionizing radiation (IR) for 4 hr. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, phospho-ATM/ATR substrates, and α-tubulin. ( F ) HeLa cells were treated with 0.5 μM DOX, and analyzed by immunoblotting for MASTL, α-tubulin, Aurora A, Aurora B, CDK1, cyclin B1, and phospho-ATM/ATR substrates. ( G ) SCC38 cells were incubated with or without HU and caffeine, as indicated, and analyzed by immunoblotting for MASTL and β-actin.

    Techniques Used: Western Blot, Incubation

    ( A–C ) HeLa cells expressing CFP-MASTL were treated without or with ionizing radiation (IR). Cells were analyzed by direct fluorescence for CFP-MASTL expression, and by immunofluorescence for the phosphorylation of ATM/ATR substrates. Quantifications are shown in panels B and C (>10 cells/time point). ( D, E ) HEK293 cells were treated without ( D ) or with ( E ) 10 mM hydroxyurea (HU) for 2 hr. These cells were then treated with cycloheximide (CHX, 20 μg/ml) at time 0 to block protein synthesis, and analyzed by immunoblotting for the protein stability of MASTL and α-tubulin.
    Figure Legend Snippet: ( A–C ) HeLa cells expressing CFP-MASTL were treated without or with ionizing radiation (IR). Cells were analyzed by direct fluorescence for CFP-MASTL expression, and by immunofluorescence for the phosphorylation of ATM/ATR substrates. Quantifications are shown in panels B and C (>10 cells/time point). ( D, E ) HEK293 cells were treated without ( D ) or with ( E ) 10 mM hydroxyurea (HU) for 2 hr. These cells were then treated with cycloheximide (CHX, 20 μg/ml) at time 0 to block protein synthesis, and analyzed by immunoblotting for the protein stability of MASTL and α-tubulin.

    Techniques Used: Expressing, Fluorescence, Immunofluorescence, Blocking Assay, Western Blot

    ( A ) The sequence alignment of the conserved E6AP Ser-218 motif in human, mouse, and Xenopus . ( B ) A phospho-specific antibody recognizing E6AP Ser-218 was generated, as described in Materials and methods. WT or E6AP knockout (KO) HEK293 cells were treated without or with 10 mM hydroxyurea (HU) for 4 hr, and analyzed by immunoblotting for phospho-E6AP Ser-218, E6AP, and α-tubulin. ( C ) HeLa cells were treated without or with 0.5 μM doxorubicin (DOX) and 5 μM KU55933 (ATMi), as indicated, for 1 hr, and analyzed by immunoblotting for phospho-ATM/ATR substrates, phospho-E6AP Ser-218, and α-tubulin. ( D ) HeLa cells were transfected with HA-tagged WT, S218A, or S218D E6AP. Cell lysates were harvested for immunoprecipitation (IP) assays. The input, MASTL IP, and a control IP using empty beads products were analyzed by immunoblotting for MASTL and HA. ( E ) HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in panel D. Cells were treated with or without 0.5 μM DOX for 3 hr, and harvested for IP assays. The input, HA IP, and a control IP using empty beads products were analyzed by immunoblotting for MASTL, phospho-E6AP Ser-218, and HA. ( F ) E6AP KO HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in panel D. Cells were treated with or without 0.5 μM DOX, incubated as indicated, and harvested for immunoblotting for MASTL and α-tubulin.
    Figure Legend Snippet: ( A ) The sequence alignment of the conserved E6AP Ser-218 motif in human, mouse, and Xenopus . ( B ) A phospho-specific antibody recognizing E6AP Ser-218 was generated, as described in Materials and methods. WT or E6AP knockout (KO) HEK293 cells were treated without or with 10 mM hydroxyurea (HU) for 4 hr, and analyzed by immunoblotting for phospho-E6AP Ser-218, E6AP, and α-tubulin. ( C ) HeLa cells were treated without or with 0.5 μM doxorubicin (DOX) and 5 μM KU55933 (ATMi), as indicated, for 1 hr, and analyzed by immunoblotting for phospho-ATM/ATR substrates, phospho-E6AP Ser-218, and α-tubulin. ( D ) HeLa cells were transfected with HA-tagged WT, S218A, or S218D E6AP. Cell lysates were harvested for immunoprecipitation (IP) assays. The input, MASTL IP, and a control IP using empty beads products were analyzed by immunoblotting for MASTL and HA. ( E ) HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in panel D. Cells were treated with or without 0.5 μM DOX for 3 hr, and harvested for IP assays. The input, HA IP, and a control IP using empty beads products were analyzed by immunoblotting for MASTL, phospho-E6AP Ser-218, and HA. ( F ) E6AP KO HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in panel D. Cells were treated with or without 0.5 μM DOX, incubated as indicated, and harvested for immunoblotting for MASTL and α-tubulin.

    Techniques Used: Sequencing, Generated, Knock-Out, Western Blot, Transfection, Immunoprecipitation, Incubation

    ( A ) WT or E6AP knockout HEK293 cells were treated without or with doxorubicin (DOX, 0.5 μM) for 4 hr. Cells were harvested and analyzed by immunoblotting for phospho-E6AP Ser-218 and α-tubulin. ( B ) HEK293 cells were treated without or with DOX (0.5 μM), or ATM inhibitor (KU55933, 10 μM), for 4 hr, and analyzed by immunoblotting. ( C ) HeLa cells were treated with hydroxyurea (HU, 10 mM) combined with ATM/ATR inhibitor (caffeine, 4 mM) or ATM inhibitor (KU55933, 10 μM), for 12 hr, as indicated. Cells were harvested and analyzed by immunoblotting.
    Figure Legend Snippet: ( A ) WT or E6AP knockout HEK293 cells were treated without or with doxorubicin (DOX, 0.5 μM) for 4 hr. Cells were harvested and analyzed by immunoblotting for phospho-E6AP Ser-218 and α-tubulin. ( B ) HEK293 cells were treated without or with DOX (0.5 μM), or ATM inhibitor (KU55933, 10 μM), for 4 hr, and analyzed by immunoblotting. ( C ) HeLa cells were treated with hydroxyurea (HU, 10 mM) combined with ATM/ATR inhibitor (caffeine, 4 mM) or ATM inhibitor (KU55933, 10 μM), for 12 hr, as indicated. Cells were harvested and analyzed by immunoblotting.

    Techniques Used: Knock-Out, Western Blot

    ( A ) E6AP knockout (KO) HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in . Cells were treated with 0.1 μM etoposide (ETO) for 18 hr, and released in fresh medium for recovery. Cells were then harvested at the indicated time points (after the removal of ETO) for immunofluorescence (IF) using an anti-phospho-Aurora A/B/C antibody. The activation of Aurora phosphorylation (shown in red) and chromosome condensation (in blue) indicated mitosis. The percentages of cells in mitosis were quantified manually and shown. The mean values and standard deviations were calculated from three experiments. An unpaired two-tailed Student’s t test was used to determine the statistical significance (**p<0.01, n>500 cell numbers/measurement). ( B ) E6AP KO HeLa cells expressing HA-tagged WT or S218A E6AP, as in panel A, were treated with 2 mM hydroxyurea (HU) for 18 hr. Cells were then released in fresh medium, and incubated as indicated, for recovery. Cell cycle progression was analyzed by fluorescence-activated cell sorting (FACS). ( C ) WT or S218A E6AP was expressed in E6AP KO HEK293 cells. Cells were treated without or with 0.1 μM ETO for 18 hr, released in fresh medium for recovery, and incubated as indicated. Cells were analyzed by immunoblotting for phospho-cyclin-dependent kinase (CDK) substrates and histone H3. ( D ) WT or S218A E6AP was expressed in E6AP KO HEK293 cells, as in panel C. Cells were treated without or with 1 μM CPT for 90 min, and analyzed by immunoblotting for phospho-ATM/ATR substrates, phospho-SMC1 Ser-957, and α-tubulin.
    Figure Legend Snippet: ( A ) E6AP knockout (KO) HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in . Cells were treated with 0.1 μM etoposide (ETO) for 18 hr, and released in fresh medium for recovery. Cells were then harvested at the indicated time points (after the removal of ETO) for immunofluorescence (IF) using an anti-phospho-Aurora A/B/C antibody. The activation of Aurora phosphorylation (shown in red) and chromosome condensation (in blue) indicated mitosis. The percentages of cells in mitosis were quantified manually and shown. The mean values and standard deviations were calculated from three experiments. An unpaired two-tailed Student’s t test was used to determine the statistical significance (**p<0.01, n>500 cell numbers/measurement). ( B ) E6AP KO HeLa cells expressing HA-tagged WT or S218A E6AP, as in panel A, were treated with 2 mM hydroxyurea (HU) for 18 hr. Cells were then released in fresh medium, and incubated as indicated, for recovery. Cell cycle progression was analyzed by fluorescence-activated cell sorting (FACS). ( C ) WT or S218A E6AP was expressed in E6AP KO HEK293 cells. Cells were treated without or with 0.1 μM ETO for 18 hr, released in fresh medium for recovery, and incubated as indicated. Cells were analyzed by immunoblotting for phospho-cyclin-dependent kinase (CDK) substrates and histone H3. ( D ) WT or S218A E6AP was expressed in E6AP KO HEK293 cells, as in panel C. Cells were treated without or with 1 μM CPT for 90 min, and analyzed by immunoblotting for phospho-ATM/ATR substrates, phospho-SMC1 Ser-957, and α-tubulin.

    Techniques Used: Knock-Out, Transfection, Immunofluorescence, Activation Assay, Two Tailed Test, Expressing, Incubation, Fluorescence, FACS, Western Blot

    human embryonic kidney hek 293 cell line  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human embryonic kidney hek 293 cell line
    Human Embryonic Kidney Hek 293 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek 293 cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney hek 293 cell line - by Bioz Stars, 2023-10
    86/100 stars

    Images

    human embryonic kidney hek 293 cell line  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human embryonic kidney hek 293 cell line
    Human Embryonic Kidney Hek 293 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek 293 cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney hek 293 cell line - by Bioz Stars, 2023-10
    86/100 stars

    Images

    cell lines human embryonic kidney hek 293  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC cell lines human embryonic kidney hek 293
    Cell Lines Human Embryonic Kidney Hek 293, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines human embryonic kidney hek 293/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cell lines human embryonic kidney hek 293 - by Bioz Stars, 2023-10
    86/100 stars

    Images

    human embryonic kidney cell line hek 293  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human embryonic kidney cell line hek 293
    Human Embryonic Kidney Cell Line Hek 293, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney cell line hek 293/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney cell line hek 293 - by Bioz Stars, 2023-10
    86/100 stars

    Images

    human embryonic kidney hek 293 crl 1573 tm cell line  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human embryonic kidney hek 293 crl 1573 tm cell line
    Human Embryonic Kidney Hek 293 Crl 1573 Tm Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek 293 crl 1573 tm cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney hek 293 crl 1573 tm cell line - by Bioz Stars, 2023-10
    86/100 stars

    Images

    human embryonic kidney hek 293 cell line  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human embryonic kidney hek 293 cell line
    Cell-based assay to evaluate the anti-IFN-I activity of NS1. ( A ) Schematic representation of plasmids, small molecules, and experimental points used for the cellular luciferase assay. The pBS IFN-β promoter-Luciferase reporter construct, the pUC57 nt shRNA (IFN-inducer), and the pFlag CMV2 NS1 (H1N1 Pdm 09) are shown. RNA Pol II promoter regions of IFN-β and the CMV virus promoters are shown as tick blue and violet arrows, respectively. RNA Pol III 7SK promoter is shown as a tick light blue arrow. Coding regions for luciferase and NS1 are shown as tick green and red rectangles, respectively. The forward and reverse sequences belonging to the nt shRNA IFN inducer are shown as petroleum and magenta rectangles, respectively. Compound x, able to act as an NS1 inhibitor, is shown as a purple-filled circle. RNA Pol II PolyA sequences and RNA Pol III terminator region are shown as mustard and red rectangles, respectively. The nt shRNA IFN inducer is shown as a 35 bp long red hairpin structure; pBS = pBluescript; 7SK p. = 7SK promoter; H1N1Pdm 09 = A(H1N1)pdm09 influenza virus; compound (Cpd). ( B ) Schematic representation of the expected outcome of transfection with different plasmid combinations and effective compound Cpd x treatment. The basal and induced luminescence signals of the IFN-β promoter luciferase construct, transfected in IFN-I competent cells alone or together with the nt shRNA (IFN inducer) expressing vector, are shown. The inhibition of luciferase signal after NS1 expressing vector co-transfection and the restoration of luciferase expression by the pretreatment with an x compound are also shown schematically. ( A , B ) were created with BioRender.com (accessed on 5 June 2023). ( C ) Evaluation of different IFN-inducer construct amounts to obtain an optimal IFN-β stimulation suitable for the assay. <t>HEK</t> <t>293</t> cells were transiently transfected with 25 ng of IFN-β promoter luciferase reporter construct alone (IFN-β p. L.) or together with increasing amounts of shRNA plasmid expressing the IFN-inducer (IFN-i). ( D ) Evaluation of the optimal NS1 expressing construct to be used in the assay. HEK 293 cells were transiently transfected with increasing amounts of pFLAG CMV2 expression A(H1N1) pdm09 NS1, together or not with the same amounts of IFN-β p. L. and IFN-I constructs used in ( A ). The green bars in both panels C and D indicate the optimal induction of the luciferase signal by the IFN-inducer (IFN-i) expression, while the red bars in panel D indicate the optimal inhibition of luciferase signal by the co-transfection of NS1 expression vector. IFN-β p. L. = IFN-β promoter Luciferase. FOI = Fold of Induction. ( E ) Expression of NS1 after transfection by Western blotting using anti-FLAG (NS1) and anti-actin (as a loading control) Antibodies. HEK 293 cells were transiently transfected with 150 ng of pFLAG CMV2 NS1 and WCE subjected to Western blotting with αFLAG monoclonal Ab, using actin as loading control, detected with αActin polyclonal Ab. Results shown in the bar graph are expressed as luciferase FOI with respect to cells transfected with the empty vector. Mean and standard deviation are shown. Statistical analysis was performed using the “two tailed unpaired t test” (( A ), left panel). * p < 0.05; ** p < 0.01; *** p < 0.001; n.s. not significant.
    Human Embryonic Kidney Hek 293 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek 293 cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney hek 293 cell line - by Bioz Stars, 2023-10
    86/100 stars

    Images

    1) Product Images from "Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy"

    Article Title: Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms241310495

    Cell-based assay to evaluate the anti-IFN-I activity of NS1. ( A ) Schematic representation of plasmids, small molecules, and experimental points used for the cellular luciferase assay. The pBS IFN-β promoter-Luciferase reporter construct, the pUC57 nt shRNA (IFN-inducer), and the pFlag CMV2 NS1 (H1N1 Pdm 09) are shown. RNA Pol II promoter regions of IFN-β and the CMV virus promoters are shown as tick blue and violet arrows, respectively. RNA Pol III 7SK promoter is shown as a tick light blue arrow. Coding regions for luciferase and NS1 are shown as tick green and red rectangles, respectively. The forward and reverse sequences belonging to the nt shRNA IFN inducer are shown as petroleum and magenta rectangles, respectively. Compound x, able to act as an NS1 inhibitor, is shown as a purple-filled circle. RNA Pol II PolyA sequences and RNA Pol III terminator region are shown as mustard and red rectangles, respectively. The nt shRNA IFN inducer is shown as a 35 bp long red hairpin structure; pBS = pBluescript; 7SK p. = 7SK promoter; H1N1Pdm 09 = A(H1N1)pdm09 influenza virus; compound (Cpd). ( B ) Schematic representation of the expected outcome of transfection with different plasmid combinations and effective compound Cpd x treatment. The basal and induced luminescence signals of the IFN-β promoter luciferase construct, transfected in IFN-I competent cells alone or together with the nt shRNA (IFN inducer) expressing vector, are shown. The inhibition of luciferase signal after NS1 expressing vector co-transfection and the restoration of luciferase expression by the pretreatment with an x compound are also shown schematically. ( A , B ) were created with BioRender.com (accessed on 5 June 2023). ( C ) Evaluation of different IFN-inducer construct amounts to obtain an optimal IFN-β stimulation suitable for the assay. HEK 293 cells were transiently transfected with 25 ng of IFN-β promoter luciferase reporter construct alone (IFN-β p. L.) or together with increasing amounts of shRNA plasmid expressing the IFN-inducer (IFN-i). ( D ) Evaluation of the optimal NS1 expressing construct to be used in the assay. HEK 293 cells were transiently transfected with increasing amounts of pFLAG CMV2 expression A(H1N1) pdm09 NS1, together or not with the same amounts of IFN-β p. L. and IFN-I constructs used in ( A ). The green bars in both panels C and D indicate the optimal induction of the luciferase signal by the IFN-inducer (IFN-i) expression, while the red bars in panel D indicate the optimal inhibition of luciferase signal by the co-transfection of NS1 expression vector. IFN-β p. L. = IFN-β promoter Luciferase. FOI = Fold of Induction. ( E ) Expression of NS1 after transfection by Western blotting using anti-FLAG (NS1) and anti-actin (as a loading control) Antibodies. HEK 293 cells were transiently transfected with 150 ng of pFLAG CMV2 NS1 and WCE subjected to Western blotting with αFLAG monoclonal Ab, using actin as loading control, detected with αActin polyclonal Ab. Results shown in the bar graph are expressed as luciferase FOI with respect to cells transfected with the empty vector. Mean and standard deviation are shown. Statistical analysis was performed using the “two tailed unpaired t test” (( A ), left panel). * p < 0.05; ** p < 0.01; *** p < 0.001; n.s. not significant.
    Figure Legend Snippet: Cell-based assay to evaluate the anti-IFN-I activity of NS1. ( A ) Schematic representation of plasmids, small molecules, and experimental points used for the cellular luciferase assay. The pBS IFN-β promoter-Luciferase reporter construct, the pUC57 nt shRNA (IFN-inducer), and the pFlag CMV2 NS1 (H1N1 Pdm 09) are shown. RNA Pol II promoter regions of IFN-β and the CMV virus promoters are shown as tick blue and violet arrows, respectively. RNA Pol III 7SK promoter is shown as a tick light blue arrow. Coding regions for luciferase and NS1 are shown as tick green and red rectangles, respectively. The forward and reverse sequences belonging to the nt shRNA IFN inducer are shown as petroleum and magenta rectangles, respectively. Compound x, able to act as an NS1 inhibitor, is shown as a purple-filled circle. RNA Pol II PolyA sequences and RNA Pol III terminator region are shown as mustard and red rectangles, respectively. The nt shRNA IFN inducer is shown as a 35 bp long red hairpin structure; pBS = pBluescript; 7SK p. = 7SK promoter; H1N1Pdm 09 = A(H1N1)pdm09 influenza virus; compound (Cpd). ( B ) Schematic representation of the expected outcome of transfection with different plasmid combinations and effective compound Cpd x treatment. The basal and induced luminescence signals of the IFN-β promoter luciferase construct, transfected in IFN-I competent cells alone or together with the nt shRNA (IFN inducer) expressing vector, are shown. The inhibition of luciferase signal after NS1 expressing vector co-transfection and the restoration of luciferase expression by the pretreatment with an x compound are also shown schematically. ( A , B ) were created with BioRender.com (accessed on 5 June 2023). ( C ) Evaluation of different IFN-inducer construct amounts to obtain an optimal IFN-β stimulation suitable for the assay. HEK 293 cells were transiently transfected with 25 ng of IFN-β promoter luciferase reporter construct alone (IFN-β p. L.) or together with increasing amounts of shRNA plasmid expressing the IFN-inducer (IFN-i). ( D ) Evaluation of the optimal NS1 expressing construct to be used in the assay. HEK 293 cells were transiently transfected with increasing amounts of pFLAG CMV2 expression A(H1N1) pdm09 NS1, together or not with the same amounts of IFN-β p. L. and IFN-I constructs used in ( A ). The green bars in both panels C and D indicate the optimal induction of the luciferase signal by the IFN-inducer (IFN-i) expression, while the red bars in panel D indicate the optimal inhibition of luciferase signal by the co-transfection of NS1 expression vector. IFN-β p. L. = IFN-β promoter Luciferase. FOI = Fold of Induction. ( E ) Expression of NS1 after transfection by Western blotting using anti-FLAG (NS1) and anti-actin (as a loading control) Antibodies. HEK 293 cells were transiently transfected with 150 ng of pFLAG CMV2 NS1 and WCE subjected to Western blotting with αFLAG monoclonal Ab, using actin as loading control, detected with αActin polyclonal Ab. Results shown in the bar graph are expressed as luciferase FOI with respect to cells transfected with the empty vector. Mean and standard deviation are shown. Statistical analysis was performed using the “two tailed unpaired t test” (( A ), left panel). * p < 0.05; ** p < 0.01; *** p < 0.001; n.s. not significant.

    Techniques Used: Cell Based Assay, Activity Assay, Luciferase, Construct, shRNA, Transfection, Plasmid Preparation, Expressing, Inhibition, Cotransfection, Western Blot, Standard Deviation, Two Tailed Test

    ( A , B ) Screening of a diverse library of compounds in the IFN-β luciferase system (treatment with compounds from 153 to 192 is shown in panel ( A ), while treatment with compounds from 193 to 236 is shown in panel ( B )). ( A ) HEK 293 cells were transiently transfected with the IFN-β promoter luciferase reporter construct alone, together with the IFN-inducer shRNA plasmid alone, or together with the pFLAG CMV2 A(H1N1)pdm09 NS1 construct. Cpds 153 to 192 of the library were added to cells at a final concentration of 50 μM in fresh medium 6 h post-transfection, and cells were harvested 42 h later (48 h after transfection) and subjected to luciferase assay. ( B ). HEK 293 cells were transiently transfected as in A, and cpds 193 to 236 of the library, were added to cells as in ( A ). The reference cpd JJ3297 was used at 5 μM. The empty vector pFLAG CMV2 was used to normalize the amount of transfected DNA in each experimental point. Results shown in the bar graph are expressed as luciferase fold of induction (FOI) with respect to cells transfected with the empty vector. Green and red bars indicate the upregulation and downregulation of luciferase activity, respectively. Blue bars underline >50% restoration obtained with the effective compounds. All experimental points were transfected with the IFN-β promoter reporter construct. The green bars in both panels indicate the induction of the luciferase signal by the IFN-inducer (IFN-i) expression (in panel ( B ), the far-right green bar also indicates the treatment with positive control JJ3297 ). DMSO (Dimethyl sulfoxide) presence is indicated in both panels.
    Figure Legend Snippet: ( A , B ) Screening of a diverse library of compounds in the IFN-β luciferase system (treatment with compounds from 153 to 192 is shown in panel ( A ), while treatment with compounds from 193 to 236 is shown in panel ( B )). ( A ) HEK 293 cells were transiently transfected with the IFN-β promoter luciferase reporter construct alone, together with the IFN-inducer shRNA plasmid alone, or together with the pFLAG CMV2 A(H1N1)pdm09 NS1 construct. Cpds 153 to 192 of the library were added to cells at a final concentration of 50 μM in fresh medium 6 h post-transfection, and cells were harvested 42 h later (48 h after transfection) and subjected to luciferase assay. ( B ). HEK 293 cells were transiently transfected as in A, and cpds 193 to 236 of the library, were added to cells as in ( A ). The reference cpd JJ3297 was used at 5 μM. The empty vector pFLAG CMV2 was used to normalize the amount of transfected DNA in each experimental point. Results shown in the bar graph are expressed as luciferase fold of induction (FOI) with respect to cells transfected with the empty vector. Green and red bars indicate the upregulation and downregulation of luciferase activity, respectively. Blue bars underline >50% restoration obtained with the effective compounds. All experimental points were transfected with the IFN-β promoter reporter construct. The green bars in both panels indicate the induction of the luciferase signal by the IFN-inducer (IFN-i) expression (in panel ( B ), the far-right green bar also indicates the treatment with positive control JJ3297 ). DMSO (Dimethyl sulfoxide) presence is indicated in both panels.

    Techniques Used: Luciferase, Transfection, Construct, shRNA, Plasmid Preparation, Concentration Assay, Activity Assay, Expressing, Positive Control

    Characterization of inhibitory compounds ( A , B ). ( A ) Confirmation experiments of compounds identified as effective in the screening. ( B ) Specificity test of the same compounds analysed in A in the absence of NS1 expressing plasmid; compound = Cpd. DMSO (Dimethyl sulfoxide) presence is indicated in both panels. H1N1Pdm 09 = A(H1N1)pdm09 influenza virus. ( A , B ) HEK 293 cells were transiently transfected with the IFN-β promoter luciferase reporter construct alone, together with the IFN-inducer nt shRNA plasmid alone, or together with the pFLAG CMV2 A(H1N1)pdm09 NS1 construct. Compounds testing positive by luciferase analysis were added to cells at a final concentration of 50 μM in fresh medium 6 h post-transfection, and cells were harvested 42 h later (48 h after transfection) and subjected to luciferase assay. Results shown in the bar graph are expressed as luciferase fold of induction (FOI) relative to cells transfected with the empty vector. Green and red bars indicate the upregulation and downregulation of luciferase activity, respectively. Blue bars underline restoration obtained with the effective compounds. Mean and standard deviation are shown. Statistical analysis was performed using the “two tailed paired t test”. * p < 0.05, ** p < 0.01, n.s. not significant.
    Figure Legend Snippet: Characterization of inhibitory compounds ( A , B ). ( A ) Confirmation experiments of compounds identified as effective in the screening. ( B ) Specificity test of the same compounds analysed in A in the absence of NS1 expressing plasmid; compound = Cpd. DMSO (Dimethyl sulfoxide) presence is indicated in both panels. H1N1Pdm 09 = A(H1N1)pdm09 influenza virus. ( A , B ) HEK 293 cells were transiently transfected with the IFN-β promoter luciferase reporter construct alone, together with the IFN-inducer nt shRNA plasmid alone, or together with the pFLAG CMV2 A(H1N1)pdm09 NS1 construct. Compounds testing positive by luciferase analysis were added to cells at a final concentration of 50 μM in fresh medium 6 h post-transfection, and cells were harvested 42 h later (48 h after transfection) and subjected to luciferase assay. Results shown in the bar graph are expressed as luciferase fold of induction (FOI) relative to cells transfected with the empty vector. Green and red bars indicate the upregulation and downregulation of luciferase activity, respectively. Blue bars underline restoration obtained with the effective compounds. Mean and standard deviation are shown. Statistical analysis was performed using the “two tailed paired t test”. * p < 0.05, ** p < 0.01, n.s. not significant.

    Techniques Used: Expressing, Plasmid Preparation, Transfection, Luciferase, Construct, shRNA, Concentration Assay, Activity Assay, Standard Deviation, Two Tailed Test

    human embryonic kidney hek 293 cell lines  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human embryonic kidney hek 293 cell lines
    SICM topography ( 1 ) and a Young’s modulus map ( 2 ) of control cells ( A , D ); cells treated with fluconazole ( B , E ); cells treated with drug L-173 ( C , F ), where PC3 is in ( A – C ) and <t>HEK</t> <t>293</t> in ( D – F ). Histogram of PC3 and HEK 293 cell stiffness with the addition of antifungals, SE and (*) p < 0.01 (one-way ANOVA) (“ns” is not significant) ( G ).
    Human Embryonic Kidney Hek 293 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek 293 cell lines/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney hek 293 cell lines - by Bioz Stars, 2023-10
    86/100 stars

    Images

    1) Product Images from "Investigation of the Antifungal and Anticancer Effects of the Novel Synthesized Thiazolidinedione by Ion-Conductance Microscopy"

    Article Title: Investigation of the Antifungal and Anticancer Effects of the Novel Synthesized Thiazolidinedione by Ion-Conductance Microscopy

    Journal: Cells

    doi: 10.3390/cells12121666

    SICM topography ( 1 ) and a Young’s modulus map ( 2 ) of control cells ( A , D ); cells treated with fluconazole ( B , E ); cells treated with drug L-173 ( C , F ), where PC3 is in ( A – C ) and HEK 293 in ( D – F ). Histogram of PC3 and HEK 293 cell stiffness with the addition of antifungals, SE and (*) p < 0.01 (one-way ANOVA) (“ns” is not significant) ( G ).
    Figure Legend Snippet: SICM topography ( 1 ) and a Young’s modulus map ( 2 ) of control cells ( A , D ); cells treated with fluconazole ( B , E ); cells treated with drug L-173 ( C , F ), where PC3 is in ( A – C ) and HEK 293 in ( D – F ). Histogram of PC3 and HEK 293 cell stiffness with the addition of antifungals, SE and (*) p < 0.01 (one-way ANOVA) (“ns” is not significant) ( G ).

    Techniques Used:

    human embryonic kidney 293 hek293 cell line  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human embryonic kidney 293 hek293 cell line
    Antioxidant activity of O. sinensis melanin. ( A ) ABTS and DPPH radical scavenging activities. ( B ) The scavenging effect of O. sinensis melanin on intracellular ROS; green fluorescence indicates DCFH-DA labeled ROS. Bar = 20 μm. ( C ) Quantification and statistical analysis of the scavenging effect of O. sinensis melanin on intracellular ROS. ( D ) Preincubation with O. sinensis melanin reduces the apoptosis induced by H 2 O 2 in <t>HEK293</t> cells. Different lowercase letters indicate significant differences between groups ( p < 0.05).
    Human Embryonic Kidney 293 Hek293 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney 293 hek293 cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney 293 hek293 cell line - by Bioz Stars, 2023-10
    86/100 stars

    Images

    1) Product Images from "Characterization and Biological Activities of Melanin from the Medicinal Fungi Ophiocordyceps sinensis"

    Article Title: Characterization and Biological Activities of Melanin from the Medicinal Fungi Ophiocordyceps sinensis

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms241210282

    Antioxidant activity of O. sinensis melanin. ( A ) ABTS and DPPH radical scavenging activities. ( B ) The scavenging effect of O. sinensis melanin on intracellular ROS; green fluorescence indicates DCFH-DA labeled ROS. Bar = 20 μm. ( C ) Quantification and statistical analysis of the scavenging effect of O. sinensis melanin on intracellular ROS. ( D ) Preincubation with O. sinensis melanin reduces the apoptosis induced by H 2 O 2 in HEK293 cells. Different lowercase letters indicate significant differences between groups ( p < 0.05).
    Figure Legend Snippet: Antioxidant activity of O. sinensis melanin. ( A ) ABTS and DPPH radical scavenging activities. ( B ) The scavenging effect of O. sinensis melanin on intracellular ROS; green fluorescence indicates DCFH-DA labeled ROS. Bar = 20 μm. ( C ) Quantification and statistical analysis of the scavenging effect of O. sinensis melanin on intracellular ROS. ( D ) Preincubation with O. sinensis melanin reduces the apoptosis induced by H 2 O 2 in HEK293 cells. Different lowercase letters indicate significant differences between groups ( p < 0.05).

    Techniques Used: Antioxidant Activity Assay, Fluorescence, Labeling

    cell lines human embryonic kidney hek 293 cell line  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC cell lines human embryonic kidney hek 293 cell line
    Single ITR plasmids reduce rAAV vector yield. Cotransfection of pH22, pFA6, and pssAAV-CB-EGFP with pCI, pCI-ITR-CBD, pCI-ITR or pRB21-ITR at the ratio of 1:1:0.1:0.9 into <t>HEK</t> <t>293</t> cells. AAV vector yield was quantified by qPCR 72-h post transfection. Significant differences in vector yield of the other groups versus pCI group denoted by a star flag. ***p < 0.001. qPCR, quantitative polymerase chain reaction.
    Cell Lines Human Embryonic Kidney Hek 293 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines human embryonic kidney hek 293 cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cell lines human embryonic kidney hek 293 cell line - by Bioz Stars, 2023-10
    86/100 stars

    Images

    1) Product Images from "Cryptic resolution sites in the vector plasmid lead to the heterogeneities in the rAAV vectors"

    Article Title: Cryptic resolution sites in the vector plasmid lead to the heterogeneities in the rAAV vectors

    Journal: Journal of medical virology

    doi: 10.1002/jmv.28433

    Single ITR plasmids reduce rAAV vector yield. Cotransfection of pH22, pFA6, and pssAAV-CB-EGFP with pCI, pCI-ITR-CBD, pCI-ITR or pRB21-ITR at the ratio of 1:1:0.1:0.9 into HEK 293 cells. AAV vector yield was quantified by qPCR 72-h post transfection. Significant differences in vector yield of the other groups versus pCI group denoted by a star flag. ***p < 0.001. qPCR, quantitative polymerase chain reaction.
    Figure Legend Snippet: Single ITR plasmids reduce rAAV vector yield. Cotransfection of pH22, pFA6, and pssAAV-CB-EGFP with pCI, pCI-ITR-CBD, pCI-ITR or pRB21-ITR at the ratio of 1:1:0.1:0.9 into HEK 293 cells. AAV vector yield was quantified by qPCR 72-h post transfection. Significant differences in vector yield of the other groups versus pCI group denoted by a star flag. ***p < 0.001. qPCR, quantitative polymerase chain reaction.

    Techniques Used: Plasmid Preparation, Cotransfection, Transfection, Real-time Polymerase Chain Reaction

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    ATCC human embryonic kidney 293 hek293 cell lines
    ( A ) <t>HEK293</t> cells were treated with 0.5 µM doxorubicin (DOX) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( B ) HEK293 cells were treated with 10 mM hydroxyurea (HU) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( C ) HEK293 cells were treated with 10 nM camptothecin (CPT) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( D ) HeLa cells were treated with 10 mM HU, and incubated as indicated. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, RPA32, phospho-ATM/ATR substrates, and α-tubulin. ( E ) HeLa cells were treated with or without 0.5 µM DOX, 10 nM CPT, 10 mM HU, and 20 Gy ionizing radiation (IR) for 4 hr. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, phospho-ATM/ATR substrates, and α-tubulin. ( F ) HeLa cells were treated with 0.5 μM DOX, and analyzed by immunoblotting for MASTL, α-tubulin, Aurora A, Aurora B, CDK1, cyclin B1, and phospho-ATM/ATR substrates. ( G ) SCC38 cells were incubated with or without HU and caffeine, as indicated, and analyzed by immunoblotting for MASTL and β-actin.
    Human Embryonic Kidney 293 Hek293 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney 293 hek293 cell lines/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney 293 hek293 cell lines - by Bioz Stars, 2023-10
    86/100 stars
      Buy from Supplier

    86
    ATCC human embryonic kidney hek 293 cell line
    ( A ) <t>HEK293</t> cells were treated with 0.5 µM doxorubicin (DOX) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( B ) HEK293 cells were treated with 10 mM hydroxyurea (HU) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( C ) HEK293 cells were treated with 10 nM camptothecin (CPT) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( D ) HeLa cells were treated with 10 mM HU, and incubated as indicated. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, RPA32, phospho-ATM/ATR substrates, and α-tubulin. ( E ) HeLa cells were treated with or without 0.5 µM DOX, 10 nM CPT, 10 mM HU, and 20 Gy ionizing radiation (IR) for 4 hr. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, phospho-ATM/ATR substrates, and α-tubulin. ( F ) HeLa cells were treated with 0.5 μM DOX, and analyzed by immunoblotting for MASTL, α-tubulin, Aurora A, Aurora B, CDK1, cyclin B1, and phospho-ATM/ATR substrates. ( G ) SCC38 cells were incubated with or without HU and caffeine, as indicated, and analyzed by immunoblotting for MASTL and β-actin.
    Human Embryonic Kidney Hek 293 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek 293 cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney hek 293 cell line - by Bioz Stars, 2023-10
    86/100 stars
      Buy from Supplier

    86
    ATCC cell lines human embryonic kidney hek 293
    ( A ) <t>HEK293</t> cells were treated with 0.5 µM doxorubicin (DOX) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( B ) HEK293 cells were treated with 10 mM hydroxyurea (HU) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( C ) HEK293 cells were treated with 10 nM camptothecin (CPT) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( D ) HeLa cells were treated with 10 mM HU, and incubated as indicated. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, RPA32, phospho-ATM/ATR substrates, and α-tubulin. ( E ) HeLa cells were treated with or without 0.5 µM DOX, 10 nM CPT, 10 mM HU, and 20 Gy ionizing radiation (IR) for 4 hr. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, phospho-ATM/ATR substrates, and α-tubulin. ( F ) HeLa cells were treated with 0.5 μM DOX, and analyzed by immunoblotting for MASTL, α-tubulin, Aurora A, Aurora B, CDK1, cyclin B1, and phospho-ATM/ATR substrates. ( G ) SCC38 cells were incubated with or without HU and caffeine, as indicated, and analyzed by immunoblotting for MASTL and β-actin.
    Cell Lines Human Embryonic Kidney Hek 293, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines human embryonic kidney hek 293/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cell lines human embryonic kidney hek 293 - by Bioz Stars, 2023-10
    86/100 stars
      Buy from Supplier

    86
    ATCC human embryonic kidney cell line hek 293
    ( A ) <t>HEK293</t> cells were treated with 0.5 µM doxorubicin (DOX) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( B ) HEK293 cells were treated with 10 mM hydroxyurea (HU) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( C ) HEK293 cells were treated with 10 nM camptothecin (CPT) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( D ) HeLa cells were treated with 10 mM HU, and incubated as indicated. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, RPA32, phospho-ATM/ATR substrates, and α-tubulin. ( E ) HeLa cells were treated with or without 0.5 µM DOX, 10 nM CPT, 10 mM HU, and 20 Gy ionizing radiation (IR) for 4 hr. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, phospho-ATM/ATR substrates, and α-tubulin. ( F ) HeLa cells were treated with 0.5 μM DOX, and analyzed by immunoblotting for MASTL, α-tubulin, Aurora A, Aurora B, CDK1, cyclin B1, and phospho-ATM/ATR substrates. ( G ) SCC38 cells were incubated with or without HU and caffeine, as indicated, and analyzed by immunoblotting for MASTL and β-actin.
    Human Embryonic Kidney Cell Line Hek 293, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney cell line hek 293/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney cell line hek 293 - by Bioz Stars, 2023-10
    86/100 stars
      Buy from Supplier

    86
    ATCC human embryonic kidney hek 293 crl 1573 tm cell line
    ( A ) <t>HEK293</t> cells were treated with 0.5 µM doxorubicin (DOX) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( B ) HEK293 cells were treated with 10 mM hydroxyurea (HU) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( C ) HEK293 cells were treated with 10 nM camptothecin (CPT) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( D ) HeLa cells were treated with 10 mM HU, and incubated as indicated. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, RPA32, phospho-ATM/ATR substrates, and α-tubulin. ( E ) HeLa cells were treated with or without 0.5 µM DOX, 10 nM CPT, 10 mM HU, and 20 Gy ionizing radiation (IR) for 4 hr. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, phospho-ATM/ATR substrates, and α-tubulin. ( F ) HeLa cells were treated with 0.5 μM DOX, and analyzed by immunoblotting for MASTL, α-tubulin, Aurora A, Aurora B, CDK1, cyclin B1, and phospho-ATM/ATR substrates. ( G ) SCC38 cells were incubated with or without HU and caffeine, as indicated, and analyzed by immunoblotting for MASTL and β-actin.
    Human Embryonic Kidney Hek 293 Crl 1573 Tm Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek 293 crl 1573 tm cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney hek 293 crl 1573 tm cell line - by Bioz Stars, 2023-10
    86/100 stars
      Buy from Supplier

    86
    ATCC human embryonic kidney hek 293 cell lines
    SICM topography ( 1 ) and a Young’s modulus map ( 2 ) of control cells ( A , D ); cells treated with fluconazole ( B , E ); cells treated with drug L-173 ( C , F ), where PC3 is in ( A – C ) and <t>HEK</t> <t>293</t> in ( D – F ). Histogram of PC3 and HEK 293 cell stiffness with the addition of antifungals, SE and (*) p < 0.01 (one-way ANOVA) (“ns” is not significant) ( G ).
    Human Embryonic Kidney Hek 293 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek 293 cell lines/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney hek 293 cell lines - by Bioz Stars, 2023-10
    86/100 stars
      Buy from Supplier

    86
    ATCC human embryonic kidney 293 hek293 cell line
    Antioxidant activity of O. sinensis melanin. ( A ) ABTS and DPPH radical scavenging activities. ( B ) The scavenging effect of O. sinensis melanin on intracellular ROS; green fluorescence indicates DCFH-DA labeled ROS. Bar = 20 μm. ( C ) Quantification and statistical analysis of the scavenging effect of O. sinensis melanin on intracellular ROS. ( D ) Preincubation with O. sinensis melanin reduces the apoptosis induced by H 2 O 2 in <t>HEK293</t> cells. Different lowercase letters indicate significant differences between groups ( p < 0.05).
    Human Embryonic Kidney 293 Hek293 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney 293 hek293 cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human embryonic kidney 293 hek293 cell line - by Bioz Stars, 2023-10
    86/100 stars
      Buy from Supplier

    86
    ATCC cell lines human embryonic kidney hek 293 cell line
    Single ITR plasmids reduce rAAV vector yield. Cotransfection of pH22, pFA6, and pssAAV-CB-EGFP with pCI, pCI-ITR-CBD, pCI-ITR or pRB21-ITR at the ratio of 1:1:0.1:0.9 into <t>HEK</t> <t>293</t> cells. AAV vector yield was quantified by qPCR 72-h post transfection. Significant differences in vector yield of the other groups versus pCI group denoted by a star flag. ***p < 0.001. qPCR, quantitative polymerase chain reaction.
    Cell Lines Human Embryonic Kidney Hek 293 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines human embryonic kidney hek 293 cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cell lines human embryonic kidney hek 293 cell line - by Bioz Stars, 2023-10
    86/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) HEK293 cells were treated with 0.5 µM doxorubicin (DOX) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( B ) HEK293 cells were treated with 10 mM hydroxyurea (HU) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( C ) HEK293 cells were treated with 10 nM camptothecin (CPT) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( D ) HeLa cells were treated with 10 mM HU, and incubated as indicated. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, RPA32, phospho-ATM/ATR substrates, and α-tubulin. ( E ) HeLa cells were treated with or without 0.5 µM DOX, 10 nM CPT, 10 mM HU, and 20 Gy ionizing radiation (IR) for 4 hr. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, phospho-ATM/ATR substrates, and α-tubulin. ( F ) HeLa cells were treated with 0.5 μM DOX, and analyzed by immunoblotting for MASTL, α-tubulin, Aurora A, Aurora B, CDK1, cyclin B1, and phospho-ATM/ATR substrates. ( G ) SCC38 cells were incubated with or without HU and caffeine, as indicated, and analyzed by immunoblotting for MASTL and β-actin.

    Journal: eLife

    Article Title: The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery

    doi: 10.7554/eLife.86976

    Figure Lengend Snippet: ( A ) HEK293 cells were treated with 0.5 µM doxorubicin (DOX) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( B ) HEK293 cells were treated with 10 mM hydroxyurea (HU) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( C ) HEK293 cells were treated with 10 nM camptothecin (CPT) as indicated, cell lysates were collected and analyzed by immunoblotting for MASTL, RPA32, and α-tubulin. ( D ) HeLa cells were treated with 10 mM HU, and incubated as indicated. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, RPA32, phospho-ATM/ATR substrates, and α-tubulin. ( E ) HeLa cells were treated with or without 0.5 µM DOX, 10 nM CPT, 10 mM HU, and 20 Gy ionizing radiation (IR) for 4 hr. Cell lysates were collected and analyzed by immunoblotting for MASTL, phospho-H2AX Ser-139, phospho-ATM/ATR substrates, and α-tubulin. ( F ) HeLa cells were treated with 0.5 μM DOX, and analyzed by immunoblotting for MASTL, α-tubulin, Aurora A, Aurora B, CDK1, cyclin B1, and phospho-ATM/ATR substrates. ( G ) SCC38 cells were incubated with or without HU and caffeine, as indicated, and analyzed by immunoblotting for MASTL and β-actin.

    Article Snippet: Human cervix carcinoma (HeLa) and human embryonic kidney 293 (HEK293) cell lines were obtained and authenticated by ATCC, and maintained in Dulbecco’s modified Eagle medium (DMEM, Hyclone) with 10% fetal bovine serum (FBS, Hyclone).

    Techniques: Western Blot, Incubation

    ( A–C ) HeLa cells expressing CFP-MASTL were treated without or with ionizing radiation (IR). Cells were analyzed by direct fluorescence for CFP-MASTL expression, and by immunofluorescence for the phosphorylation of ATM/ATR substrates. Quantifications are shown in panels B and C (>10 cells/time point). ( D, E ) HEK293 cells were treated without ( D ) or with ( E ) 10 mM hydroxyurea (HU) for 2 hr. These cells were then treated with cycloheximide (CHX, 20 μg/ml) at time 0 to block protein synthesis, and analyzed by immunoblotting for the protein stability of MASTL and α-tubulin.

    Journal: eLife

    Article Title: The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery

    doi: 10.7554/eLife.86976

    Figure Lengend Snippet: ( A–C ) HeLa cells expressing CFP-MASTL were treated without or with ionizing radiation (IR). Cells were analyzed by direct fluorescence for CFP-MASTL expression, and by immunofluorescence for the phosphorylation of ATM/ATR substrates. Quantifications are shown in panels B and C (>10 cells/time point). ( D, E ) HEK293 cells were treated without ( D ) or with ( E ) 10 mM hydroxyurea (HU) for 2 hr. These cells were then treated with cycloheximide (CHX, 20 μg/ml) at time 0 to block protein synthesis, and analyzed by immunoblotting for the protein stability of MASTL and α-tubulin.

    Article Snippet: Human cervix carcinoma (HeLa) and human embryonic kidney 293 (HEK293) cell lines were obtained and authenticated by ATCC, and maintained in Dulbecco’s modified Eagle medium (DMEM, Hyclone) with 10% fetal bovine serum (FBS, Hyclone).

    Techniques: Expressing, Fluorescence, Immunofluorescence, Blocking Assay, Western Blot

    ( A ) The sequence alignment of the conserved E6AP Ser-218 motif in human, mouse, and Xenopus . ( B ) A phospho-specific antibody recognizing E6AP Ser-218 was generated, as described in Materials and methods. WT or E6AP knockout (KO) HEK293 cells were treated without or with 10 mM hydroxyurea (HU) for 4 hr, and analyzed by immunoblotting for phospho-E6AP Ser-218, E6AP, and α-tubulin. ( C ) HeLa cells were treated without or with 0.5 μM doxorubicin (DOX) and 5 μM KU55933 (ATMi), as indicated, for 1 hr, and analyzed by immunoblotting for phospho-ATM/ATR substrates, phospho-E6AP Ser-218, and α-tubulin. ( D ) HeLa cells were transfected with HA-tagged WT, S218A, or S218D E6AP. Cell lysates were harvested for immunoprecipitation (IP) assays. The input, MASTL IP, and a control IP using empty beads products were analyzed by immunoblotting for MASTL and HA. ( E ) HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in panel D. Cells were treated with or without 0.5 μM DOX for 3 hr, and harvested for IP assays. The input, HA IP, and a control IP using empty beads products were analyzed by immunoblotting for MASTL, phospho-E6AP Ser-218, and HA. ( F ) E6AP KO HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in panel D. Cells were treated with or without 0.5 μM DOX, incubated as indicated, and harvested for immunoblotting for MASTL and α-tubulin.

    Journal: eLife

    Article Title: The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery

    doi: 10.7554/eLife.86976

    Figure Lengend Snippet: ( A ) The sequence alignment of the conserved E6AP Ser-218 motif in human, mouse, and Xenopus . ( B ) A phospho-specific antibody recognizing E6AP Ser-218 was generated, as described in Materials and methods. WT or E6AP knockout (KO) HEK293 cells were treated without or with 10 mM hydroxyurea (HU) for 4 hr, and analyzed by immunoblotting for phospho-E6AP Ser-218, E6AP, and α-tubulin. ( C ) HeLa cells were treated without or with 0.5 μM doxorubicin (DOX) and 5 μM KU55933 (ATMi), as indicated, for 1 hr, and analyzed by immunoblotting for phospho-ATM/ATR substrates, phospho-E6AP Ser-218, and α-tubulin. ( D ) HeLa cells were transfected with HA-tagged WT, S218A, or S218D E6AP. Cell lysates were harvested for immunoprecipitation (IP) assays. The input, MASTL IP, and a control IP using empty beads products were analyzed by immunoblotting for MASTL and HA. ( E ) HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in panel D. Cells were treated with or without 0.5 μM DOX for 3 hr, and harvested for IP assays. The input, HA IP, and a control IP using empty beads products were analyzed by immunoblotting for MASTL, phospho-E6AP Ser-218, and HA. ( F ) E6AP KO HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in panel D. Cells were treated with or without 0.5 μM DOX, incubated as indicated, and harvested for immunoblotting for MASTL and α-tubulin.

    Article Snippet: Human cervix carcinoma (HeLa) and human embryonic kidney 293 (HEK293) cell lines were obtained and authenticated by ATCC, and maintained in Dulbecco’s modified Eagle medium (DMEM, Hyclone) with 10% fetal bovine serum (FBS, Hyclone).

    Techniques: Sequencing, Generated, Knock-Out, Western Blot, Transfection, Immunoprecipitation, Incubation

    ( A ) WT or E6AP knockout HEK293 cells were treated without or with doxorubicin (DOX, 0.5 μM) for 4 hr. Cells were harvested and analyzed by immunoblotting for phospho-E6AP Ser-218 and α-tubulin. ( B ) HEK293 cells were treated without or with DOX (0.5 μM), or ATM inhibitor (KU55933, 10 μM), for 4 hr, and analyzed by immunoblotting. ( C ) HeLa cells were treated with hydroxyurea (HU, 10 mM) combined with ATM/ATR inhibitor (caffeine, 4 mM) or ATM inhibitor (KU55933, 10 μM), for 12 hr, as indicated. Cells were harvested and analyzed by immunoblotting.

    Journal: eLife

    Article Title: The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery

    doi: 10.7554/eLife.86976

    Figure Lengend Snippet: ( A ) WT or E6AP knockout HEK293 cells were treated without or with doxorubicin (DOX, 0.5 μM) for 4 hr. Cells were harvested and analyzed by immunoblotting for phospho-E6AP Ser-218 and α-tubulin. ( B ) HEK293 cells were treated without or with DOX (0.5 μM), or ATM inhibitor (KU55933, 10 μM), for 4 hr, and analyzed by immunoblotting. ( C ) HeLa cells were treated with hydroxyurea (HU, 10 mM) combined with ATM/ATR inhibitor (caffeine, 4 mM) or ATM inhibitor (KU55933, 10 μM), for 12 hr, as indicated. Cells were harvested and analyzed by immunoblotting.

    Article Snippet: Human cervix carcinoma (HeLa) and human embryonic kidney 293 (HEK293) cell lines were obtained and authenticated by ATCC, and maintained in Dulbecco’s modified Eagle medium (DMEM, Hyclone) with 10% fetal bovine serum (FBS, Hyclone).

    Techniques: Knock-Out, Western Blot

    ( A ) E6AP knockout (KO) HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in . Cells were treated with 0.1 μM etoposide (ETO) for 18 hr, and released in fresh medium for recovery. Cells were then harvested at the indicated time points (after the removal of ETO) for immunofluorescence (IF) using an anti-phospho-Aurora A/B/C antibody. The activation of Aurora phosphorylation (shown in red) and chromosome condensation (in blue) indicated mitosis. The percentages of cells in mitosis were quantified manually and shown. The mean values and standard deviations were calculated from three experiments. An unpaired two-tailed Student’s t test was used to determine the statistical significance (**p<0.01, n>500 cell numbers/measurement). ( B ) E6AP KO HeLa cells expressing HA-tagged WT or S218A E6AP, as in panel A, were treated with 2 mM hydroxyurea (HU) for 18 hr. Cells were then released in fresh medium, and incubated as indicated, for recovery. Cell cycle progression was analyzed by fluorescence-activated cell sorting (FACS). ( C ) WT or S218A E6AP was expressed in E6AP KO HEK293 cells. Cells were treated without or with 0.1 μM ETO for 18 hr, released in fresh medium for recovery, and incubated as indicated. Cells were analyzed by immunoblotting for phospho-cyclin-dependent kinase (CDK) substrates and histone H3. ( D ) WT or S218A E6AP was expressed in E6AP KO HEK293 cells, as in panel C. Cells were treated without or with 1 μM CPT for 90 min, and analyzed by immunoblotting for phospho-ATM/ATR substrates, phospho-SMC1 Ser-957, and α-tubulin.

    Journal: eLife

    Article Title: The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery

    doi: 10.7554/eLife.86976

    Figure Lengend Snippet: ( A ) E6AP knockout (KO) HeLa cells were transfected with HA-tagged WT or S218A E6AP, as in . Cells were treated with 0.1 μM etoposide (ETO) for 18 hr, and released in fresh medium for recovery. Cells were then harvested at the indicated time points (after the removal of ETO) for immunofluorescence (IF) using an anti-phospho-Aurora A/B/C antibody. The activation of Aurora phosphorylation (shown in red) and chromosome condensation (in blue) indicated mitosis. The percentages of cells in mitosis were quantified manually and shown. The mean values and standard deviations were calculated from three experiments. An unpaired two-tailed Student’s t test was used to determine the statistical significance (**p<0.01, n>500 cell numbers/measurement). ( B ) E6AP KO HeLa cells expressing HA-tagged WT or S218A E6AP, as in panel A, were treated with 2 mM hydroxyurea (HU) for 18 hr. Cells were then released in fresh medium, and incubated as indicated, for recovery. Cell cycle progression was analyzed by fluorescence-activated cell sorting (FACS). ( C ) WT or S218A E6AP was expressed in E6AP KO HEK293 cells. Cells were treated without or with 0.1 μM ETO for 18 hr, released in fresh medium for recovery, and incubated as indicated. Cells were analyzed by immunoblotting for phospho-cyclin-dependent kinase (CDK) substrates and histone H3. ( D ) WT or S218A E6AP was expressed in E6AP KO HEK293 cells, as in panel C. Cells were treated without or with 1 μM CPT for 90 min, and analyzed by immunoblotting for phospho-ATM/ATR substrates, phospho-SMC1 Ser-957, and α-tubulin.

    Article Snippet: Human cervix carcinoma (HeLa) and human embryonic kidney 293 (HEK293) cell lines were obtained and authenticated by ATCC, and maintained in Dulbecco’s modified Eagle medium (DMEM, Hyclone) with 10% fetal bovine serum (FBS, Hyclone).

    Techniques: Knock-Out, Transfection, Immunofluorescence, Activation Assay, Two Tailed Test, Expressing, Incubation, Fluorescence, FACS, Western Blot

    SICM topography ( 1 ) and a Young’s modulus map ( 2 ) of control cells ( A , D ); cells treated with fluconazole ( B , E ); cells treated with drug L-173 ( C , F ), where PC3 is in ( A – C ) and HEK 293 in ( D – F ). Histogram of PC3 and HEK 293 cell stiffness with the addition of antifungals, SE and (*) p < 0.01 (one-way ANOVA) (“ns” is not significant) ( G ).

    Journal: Cells

    Article Title: Investigation of the Antifungal and Anticancer Effects of the Novel Synthesized Thiazolidinedione by Ion-Conductance Microscopy

    doi: 10.3390/cells12121666

    Figure Lengend Snippet: SICM topography ( 1 ) and a Young’s modulus map ( 2 ) of control cells ( A , D ); cells treated with fluconazole ( B , E ); cells treated with drug L-173 ( C , F ), where PC3 is in ( A – C ) and HEK 293 in ( D – F ). Histogram of PC3 and HEK 293 cell stiffness with the addition of antifungals, SE and (*) p < 0.01 (one-way ANOVA) (“ns” is not significant) ( G ).

    Article Snippet: Human prostate adenocarcinoma PC3 and human embryonic kidney HEK 293 cell lines (ATCC, Manassas, VA, USA) were cultured in Dulbecco’s modified Eagle’s medium/Nutrient Mixture F-12 (Gibco, Grand Island, NE, USA) containing 1% GlutaMAX (Gibco, USA), 1% Penicillin-Streptomycin (Gibco, USA), 10% fetal bovine serum (Gibco, USA) and maintained in a humidified incubator at 5% CO 2 and 37 °C.

    Techniques:

    Antioxidant activity of O. sinensis melanin. ( A ) ABTS and DPPH radical scavenging activities. ( B ) The scavenging effect of O. sinensis melanin on intracellular ROS; green fluorescence indicates DCFH-DA labeled ROS. Bar = 20 μm. ( C ) Quantification and statistical analysis of the scavenging effect of O. sinensis melanin on intracellular ROS. ( D ) Preincubation with O. sinensis melanin reduces the apoptosis induced by H 2 O 2 in HEK293 cells. Different lowercase letters indicate significant differences between groups ( p < 0.05).

    Journal: International Journal of Molecular Sciences

    Article Title: Characterization and Biological Activities of Melanin from the Medicinal Fungi Ophiocordyceps sinensis

    doi: 10.3390/ijms241210282

    Figure Lengend Snippet: Antioxidant activity of O. sinensis melanin. ( A ) ABTS and DPPH radical scavenging activities. ( B ) The scavenging effect of O. sinensis melanin on intracellular ROS; green fluorescence indicates DCFH-DA labeled ROS. Bar = 20 μm. ( C ) Quantification and statistical analysis of the scavenging effect of O. sinensis melanin on intracellular ROS. ( D ) Preincubation with O. sinensis melanin reduces the apoptosis induced by H 2 O 2 in HEK293 cells. Different lowercase letters indicate significant differences between groups ( p < 0.05).

    Article Snippet: Human hepatocellular carcinoma (HepG2) cell line (HB-8065, ATCC), mouse leukemia cells of monocyte-macrophage (RAW264.7) cell line (TIB-71, ATCC), dendritic (DC2.4) cell line (HTX2245, ATCC), human colon cancer (SW620) cell line (CCL-227, ATCC), and human embryonic kidney 293 (HEK293) cell line (CRL-1573, ATCC) were purchased from the American Type Culture Collection and grown in complete growth medium supplemented with 10% fetal bovine serum (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) at 37 °C with 5% CO 2 .

    Techniques: Antioxidant Activity Assay, Fluorescence, Labeling

    Single ITR plasmids reduce rAAV vector yield. Cotransfection of pH22, pFA6, and pssAAV-CB-EGFP with pCI, pCI-ITR-CBD, pCI-ITR or pRB21-ITR at the ratio of 1:1:0.1:0.9 into HEK 293 cells. AAV vector yield was quantified by qPCR 72-h post transfection. Significant differences in vector yield of the other groups versus pCI group denoted by a star flag. ***p < 0.001. qPCR, quantitative polymerase chain reaction.

    Journal: Journal of medical virology

    Article Title: Cryptic resolution sites in the vector plasmid lead to the heterogeneities in the rAAV vectors

    doi: 10.1002/jmv.28433

    Figure Lengend Snippet: Single ITR plasmids reduce rAAV vector yield. Cotransfection of pH22, pFA6, and pssAAV-CB-EGFP with pCI, pCI-ITR-CBD, pCI-ITR or pRB21-ITR at the ratio of 1:1:0.1:0.9 into HEK 293 cells. AAV vector yield was quantified by qPCR 72-h post transfection. Significant differences in vector yield of the other groups versus pCI group denoted by a star flag. ***p < 0.001. qPCR, quantitative polymerase chain reaction.

    Article Snippet: Cell lines Human embryonic kidney (HEK) 293 cell line was purchased from ATCC.

    Techniques: Plasmid Preparation, Cotransfection, Transfection, Real-time Polymerase Chain Reaction